SignatureFD’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

SignatureFD’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,500	Closed	-$137K	–	3473
2022 Q2	$137K	Hold	2,500	–	–	﹤0.01%	839
2022 Q1	$80K	Hold	2,500	–	–	﹤0.01%	1150
2021 Q4	$54K	Hold	2,500	–	–	﹤0.01%	1308
2021 Q3	$55K	Hold	2,500	–	–	﹤0.01%	1261
2021 Q2	$49K	Hold	2,500	–	–	﹤0.01%	1277
2021 Q1	$43K	Hold	2,500	–	–	﹤0.01%	1246
2020 Q4	$40K	Sell	2,500 -2,500	-50%	-$34.7K	﹤0.01%	1185
2020 Q3	$53K	Hold	5,000	–	–	﹤0.01%	958
2020 Q2	$61K	Buy	+5,000	New	+$62K	﹤0.01%	882

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

SignatureFD's SRRA Position: Q3 2022 in Review

SignatureFD sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 2,500 shares — an estimated $137K sold.

SignatureFD first reported a position in SRRA in Q2 2020 and held it in 9 quarters. The position peaked at $137K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

SignatureFD reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
SignatureFD sold 2,500 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $137K.
SignatureFD first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
SignatureFD's Sierra Oncology, Inc. Common Stock position peaked at $137K in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on SignatureFD's 13F filing for Q3 2022, filed 8 Nov 2022.